$cno 2011 Q4 10-K

Concept	2011 Q4	2011 Q3	2011 Q2
Revenue	$1.051B	$992.3M	$1.032B
YoY Change	-2.3%	-5.72%	8.27%
Cost Of Revenue		$661.0M	$684.4M
YoY Change		-5.57%	5.13%
Gross Profit		$331.3M	$347.6M
YoY Change		-6.01%	15.02%
Gross Profit Margin		33.39%	33.68%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		-$35.50M	-$42.40M
YoY Change
% of Gross Profit		-10.72%	-12.2%
Operating Expenses	$920.4M	$901.6M	$930.7M
YoY Change	-1.22%	-4.77%	6.76%
Operating Profit		-$570.3M	-$583.1M
YoY Change		-4.04%	2.37%
Interest Expense	-$28.10M	$27.90M	$28.90M
YoY Change	-1.75%	-1.76%	0.7%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$102.3M	$61.70M	$71.80M
YoY Change	0.49%	2.15%	127.22%
Income Tax	-$37.90M	$117.8M	-$25.40M
% Of Pretax Income	-37.05%	190.92%	-35.38%
Net Earnings	$64.40M	$179.5M	$46.40M
YoY Change	-60.27%	365.03%	130.85%
Net Earnings / Revenue	6.13%	18.09%	4.5%
Basic Earnings Per Share	$0.27	$0.73	$0.18
Diluted Earnings Per Share	$0.23	$0.61	$0.16
COMMON SHARES
Basic Shares Outstanding	234.3M shares	247.0M shares	250.9M shares
Diluted Shares Outstanding		302.7M shares	308.0M shares

Concept	2011 Q4	2011 Q3	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$436.0M	$461.9M	$580.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$26.36B	$25.84B	$24.54B
YoY Change	10.86%	6.76%	5.34%
Other Assets	$940.0M	$938.0M	$1.024B
YoY Change	8.55%	69.01%	30.78%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$32.92B	$32.93B	$32.40B
YoY Change	4.86%	2.98%	3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$2.196B	$1.915B	$1.623B
YoY Change	38.03%	77.48%	64.6%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.230B	$2.901B	$2.601B
YoY Change	26.17%	43.76%	34.63%
LONG-TERM LIABILITIES
Long-Term Debt	$858.0M	$871.0M	$935.0M
YoY Change	-14.11%	-15.44%	-9.14%
Other Long-Term Liabilities	$556.0M	$585.0M	$712.0M
YoY Change	12.1%	-29.86%	4.09%
Total Long-Term Liabilities	$1.414B	$1.456B	$1.647B
YoY Change	-5.42%	-21.89%	-3.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.230B	$2.901B	$2.601B
Total Long-Term Liabilities	$1.414B	$1.456B	$1.647B
Total Liabilities	$28.31B	$27.98B	$27.83B
YoY Change	2.63%	2.22%	2.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$532.1M	-$30.30M	-$226.3M
YoY Change	-38.68%
Common Stock	$4.364B	$4.382B	$4.417B
YoY Change	-1.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.614B	$4.536B	$4.036B
YoY Change
Total Liabilities & Shareholders Equity	$32.92B	$32.93B	$32.40B
YoY Change	4.86%	2.98%	3.77%

Concept	2011 Q4	2011 Q3	2011 Q2
OPERATING ACTIVITIES
Net Income	$64.40M	$179.5M	$46.40M
YoY Change	-60.27%	365.03%	130.85%
Depreciation, Depletion And Amortization		-$35.50M	-$42.40M
YoY Change
Cash From Operating Activities	$212.6M	$201.4M	$205.5M
YoY Change	1.53%	-8.5%	66.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$508.9M	-$539.1M	-$100.7M
YoY Change	-21.05%	173.52%	5.22%
Cash From Investing Activities	-$508.9M	-$539.1M	-$100.7M
YoY Change	-21.05%	173.52%	5.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	270.4M	219.4M	50.80M
YoY Change	-41.0%	8.56%	-302.39%
NET CHANGE
Cash From Operating Activities	212.6M	201.4M	205.5M
Cash From Investing Activities	-508.9M	-539.1M	-100.7M
Cash From Financing Activities	270.4M	219.4M	50.80M
Net Change In Cash	-25.90M	-118.3M	155.6M
YoY Change	-212.12%	-152.55%	5884.62%
FREE CASH FLOW
Cash From Operating Activities	$212.6M	$201.4M	$205.5M
Capital Expenditures
Free Cash Flow
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	19600000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	25700000	USD
CY2012Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	286200000	USD
CY2011Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	288700000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	781600000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1197400000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4361900000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4174700000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	4000000	USD
CY2011	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	297400000	USD
CY2010	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	325000000	USD
CY2012	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	289000000	USD
CY2012Q4	us-gaap	Assets Assets	34131400000	USD
CY2011Q4	us-gaap	Assets Assets	32921900000	USD
CY2012Q4	us-gaap	Assets Held By Insurance Regulators AssetsHeldByInsuranceRegulators	67800000	USD
CY2011Q4	us-gaap	Assets Held By Insurance Regulators AssetsHeldByInsuranceRegulators	74500000	USD
CY2010	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	92600000	USD
CY2012	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	69400000	USD
CY2011	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	80400000	USD
CY2011Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21779100000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21626800000	USD
CY2012Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	167100000	USD
CY2011Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	177000000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	908600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	3768500000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	479400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2932600000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	429200000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	835900000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	4375000000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	4932700000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1605000000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1754500000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10390700000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12225100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	21779100000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	21626800000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	167600000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	170200000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5088500000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5531600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	23516000000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	24614100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	175100000	USD
CY2012Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	171400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	23516000000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	24614100000	USD
CY2010	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	347100000	USD
CY2011	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	183100000	USD
CY2012	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	115400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	222900000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	32900000	USD
CY2012Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	18700000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	118900000	USD
CY2012Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2	32900000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2	222900000	USD
CY2012Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	14200000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	104000000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1959800000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	3020200000	USD
CY2010	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3859000000	USD
CY2011	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3818400000	USD
CY2012	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	4187000000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	436000000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582500000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	571900000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	523400000	USD
CY2010	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	48500000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-135900000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	146500000	USD
CY2010	us-gaap	Ceded Premiums Written CededPremiumsWritten	258600000	USD
CY2012	us-gaap	Ceded Premiums Written CededPremiumsWritten	220000000	USD
CY2011	us-gaap	Ceded Premiums Written CededPremiumsWritten	238100000	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	6.50
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.02
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	221502371	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	241304503	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	241304503	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	221502371	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	2200000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	2400000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	636800000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	767300000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	864600000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12500000	USD
CY2010	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9700000	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11900000	USD
CY2012Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	5.49
CY2010	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	69600000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	101600000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	117400000	USD
CY2011	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-143000000	USD
CY2012	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-171500000	USD
CY2010	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-95000000	USD
CY2012	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	195500000	USD
CY2011	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	183700000	USD
CY2010	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	186000000	USD
CY2012Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	629700000	USD
CY2011Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	797100000	USD
CY2012	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	191700000	USD
CY2010	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	231800000	USD
CY2011	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	216700000	USD
CY2010Q4	us-gaap	Deferred Policy Acquisition Costs Net DeferredPolicyAcquisitionCostsNet	999600000	USD
CY2012Q4	us-gaap	Deferred Policy Acquisition Costs Net DeferredPolicyAcquisitionCostsNet	629700000	USD
CY2009Q4	us-gaap	Deferred Policy Acquisition Costs Net DeferredPolicyAcquisitionCostsNet	1063000000	USD
CY2011Q4	us-gaap	Deferred Policy Acquisition Costs Net DeferredPolicyAcquisitionCostsNet	797100000	USD
CY2012	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	4400000	USD
CY2011	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	11500000	USD
CY2010	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	20000000	USD
CY2011	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	28700000	USD
CY2010	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	31200000	USD
CY2012	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	27100000	USD
CY2012Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	126500000	USD
CY2011Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	149200000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	296200000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	342300000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2646100000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2514100000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	716900000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	865400000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	885000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	742600000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	1330200000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	1445200000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	16800000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	16200000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	64800000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	86000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	39200000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	32600000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	746300000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	744400000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	766900000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	938400000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	822700000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1004600000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	363700000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	325200000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	24200000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	24100000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	-434800000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	-655300000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4500000	USD
CY2010	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4100000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4500000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	315000000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	323600000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	346500000	USD
CY2012	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting for Derivatives</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.  We reflect changes in the estimated fair value of these options in net investment income (classified as investment income from policyholder and reinsurer accounts and other special-purpose portfolios).  Net investment gains (losses) related to fixed index products were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$(21.2) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$28.2 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2010</font><font style="font-family:inherit;font-size:10pt;">, respectively. These amounts were substantially offset by a corresponding change to insurance policy benefits.  The estimated fair value of these options was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$54.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$37.9 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively.  We classify these instruments as other invested assets.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for the options attributed to the policyholder for the estimated life of the annuity contract as embedded derivatives.  The Company purchases options to hedge liabilities for the next policy year on each policy anniversary date and must estimate the fair value of the forward embedded options related to the policies.  These accounting requirements often create volatility in the earnings from these products.  We record the changes in the fair values of the embedded derivatives in earnings as a component of insurance policy benefits.  The fair value of these derivatives, which are classified as "liabilities for interest-sensitive products", was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$734.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$666.3 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively. Prior to June 30, 2011, we maintained a specific block of investments in our trading securities account (which we carried at estimated fair value with changes in such value recognized as investment income from policyholder and reinsurer accounts and other special-purpose portfolios) to offset the income statement volatility caused by the effect of interest rate fluctuations on the value of embedded derivatives related to our fixed index annuity products.  During the second quarter of 2011, we sold this trading portfolio. Because we no longer seek to offset changes from the effect of interest rates on derivative embedded in our fixed index annuity products, we recognized </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20.4 million</font><font style="font-family:inherit;font-size:10pt;"> of decreased earnings in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively, since the volatility caused by the accounting requirements to record embedded options at fair value was no longer being offset.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the counterparties for the call options we hold fail to meet their obligations, we may have to recognize a loss.  We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy.  At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;">, substantially all of our counterparties were rated "BBB+" or higher by Standard & Poor's Corporation ("S&P").</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of our reinsurance payable balances contain embedded derivatives.  Such derivatives had an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively.  We record the change in the fair value of these derivatives as a component of investment income (classified as investment income from policyholder and reinsurer accounts and other special-purpose portfolios).  We maintain the investments related to these agreements in our trading securities account, which we carry at estimated fair value with changes in such value recognized as investment income (also classified as investment income from policyholder and reinsurer accounts and other special-purpose portfolios).  The change in value of these trading securities offsets the change in value of the embedded derivatives.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We purchase certain fixed maturity securities that contain embedded derivatives that are required to be bifurcated from the instrument and held at fair value on the consolidated balance sheet. For certain of these securities, we have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income for operational ease.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2011	us-gaap	Direct Premiums Written DirectPremiumsWritten	4214700000	USD
CY2012	us-gaap	Direct Premiums Written DirectPremiumsWritten	3883100000	USD
CY2010	us-gaap	Direct Premiums Written DirectPremiumsWritten	4252000000	USD
CY2012	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13900000	USD
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.35
CY2010	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.96
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2010	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.419
CY2010	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.070
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.096
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.467
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.422
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1.101
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.006
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.007
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.323
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005
CY2010	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.009
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.014
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.009
CY2010	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	USD
CY2011	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-34400000	USD
CY2012	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-4400000	USD
CY2011	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0	USD
CY2010	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0	USD
CY2012	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	-23700000	USD
CY2012	us-gaap	Fees And Commissions FeesAndCommissions	19800000	USD
CY2010	us-gaap	Fees And Commissions FeesAndCommissions	16800000	USD
CY2011	us-gaap	Fees And Commissions FeesAndCommissions	18200000	USD
CY2012	us-gaap	Gain Loss On Investments GainLossOnInvestments	81100000	USD
CY2011	us-gaap	Gain Loss On Investments GainLossOnInvestments	61800000	USD
CY2010	us-gaap	Gain Loss On Investments GainLossOnInvestments	30200000	USD
CY2010	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	180000000	USD
CY2012	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	118900000	USD
CY2011	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	96400000	USD
CY2010	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6800000	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-200200000	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3400000	USD
CY2010	us-gaap	Impairment Of Investments ImpairmentOfInvestments	146800000	USD
CY2011	us-gaap	Impairment Of Investments ImpairmentOfInvestments	39900000	USD
CY2012	us-gaap	Impairment Of Investments ImpairmentOfInvestments	37800000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	224900000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	155700000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	306200000	USD
CY2011Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	102300000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	61700000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	92300000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	104500000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-158800000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	71800000	USD
CY2011Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	70400000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	117700000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-29500000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-65300000	USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15700000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-33200000	USD
CY2011Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25000000	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	153800000	USD
CY2011Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37900000	USD
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16500000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-38800000	USD
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25400000	USD
CY2011Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117800000	USD
CY2011Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	865400000	USD
CY2012Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	716900000	USD
CY2010	us-gaap	Income Taxes Paid IncomeTaxesPaid	400000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	6500000	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	3400000	USD
CY2011	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-32900000	USD
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-71800000	USD
CY2010	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-16100000	USD
CY2010	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	103700000	USD
CY2012	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	0	USD
CY2011	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	0	USD
CY2010	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	225200000	USD
CY2012	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	191700000	USD
CY2011	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	216700000	USD
CY2011	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	346400000	USD
CY2012	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	330000000	USD
CY2010	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	437600000	USD
CY2012	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	0	USD
CY2011	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	0	USD
CY2010	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-103700000	USD
CY2012	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-20800000	USD
CY2011	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-17200000	USD
CY2010	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-2900000	USD
CY2010	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	943000	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	249000	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	53367000	shares
CY2010	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	49014000	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	44037000	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2513000	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2762000	shares
CY2010	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1871000	shares
CY2011	us-gaap	Insurance Commissions InsuranceCommissions	131700000	USD
CY2012	us-gaap	Insurance Commissions InsuranceCommissions	115800000	USD
CY2010	us-gaap	Insurance Commissions InsuranceCommissions	130900000	USD
CY2012	us-gaap	Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits	0.05
CY2012	us-gaap	Interest Expense InterestExpense	114600000	USD
CY2011	us-gaap	Interest Expense InterestExpense	114100000	USD
CY2010	us-gaap	Interest Expense InterestExpense	113200000	USD
CY2010	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	13300000	USD
CY2012	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	12200000	USD
CY2011	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	14700000	USD
CY2011	us-gaap	Interest Paid InterestPaid	95500000	USD
CY2012	us-gaap	Interest Paid InterestPaid	109000000	USD
CY2010	us-gaap	Interest Paid InterestPaid	108200000	USD
CY2012Q4	us-gaap	Investments Investments	27959300000	USD
CY2011Q4	us-gaap	Investments Investments	26364300000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	28308100000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	29082100000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32921900000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34131400000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	985100000	USD
CY2011Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1034300000	USD
CY2012Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11196300000	USD
CY2011Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	10482700000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid	1492700000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid	1555200000	USD
CY2010	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid	1521100000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear	891300000	USD
CY2010	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear	827000000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear	866500000	USD
CY2010	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears	694100000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears	663900000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears	626200000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims	1513700000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims	1504100000	USD
CY2010	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims	1490200000	USD
CY2010	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear	1505800000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear	1570100000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear	1545800000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears	-41700000	USD
CY2010	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears	-15600000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears	-56400000	USD
CY2011Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	1637300000	USD
CY2010Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	1543700000	USD
CY2012Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	1679300000	USD
CY2009Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	1444000000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	1012600000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	664100000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	51100000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	4200000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	153500000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	79200000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	60500000	USD
CY2011Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset	19600000	USD
CY2012Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset	24000000	USD
CY2012	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> LITIGATION AND OTHER LEGAL PROCEEDINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, many of the matters specifically identified below purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company can not reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost of Insurance Litigation</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Valulife/Valuterm Litigation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 4, 2008, a complaint was filed in the United States District Court for the Central District of California, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Celedonia X. Yue, M. D. on behalf of the class of all others similarly situated, and on behalf of the General Public v. Conseco Life Insurance Company, successor to Philadelphia Life Insurance Company and formerly known as Massachusetts General Life Insurance Company, Cause No. CV08-01506 CAS. </font><font style="font-family:inherit;font-size:10pt;"> Plaintiff in this putative class action owns a Valulife universal life policy insuring the life of Ruth S. Yue originally issued by Massachusetts General Life Insurance Company in 1995.  Plaintiff is claiming breach of contract on behalf of the proposed national class and seeks injunctive and restitutionary relief pursuant to California Business & Professions Code Section 17200 and declaratory relief.  The putative class consists of all owners of Valulife and Valuterm universal life insurance policies issued by either Massachusetts General or Philadelphia Life and that were later acquired and serviced by Conseco Life.  Plaintiff alleges that members of the class will be damaged by increases in the cost of insurance (a non-guaranteed element ("NGE")) that are set to take place in the twenty first policy year of Valulife and Valuterm policies. At the time plaintiff filed her complaint, no such increases had yet been applied to the subject policies.  During 2010, Conseco Life voluntarily agreed not to implement the cost of insurance rate increase at issue in this litigation and is following a process with respect to any future cost of insurance rate increases as set forth in the regulatory settlement agreement described below under the caption entitled "Regulatory Examinations and Fines".  Plaintiff filed a motion for certification of a nationwide class and a California state class.  On December 7, 2009, the court granted that motion. On October 8, 2010, the court dismissed the causes of actions alleged in the California state class.  On January 19, 2011, the court granted the plaintiff's motion for summary judgment as to the declaratory relief claim and on February 2, 2011, the court issued an advisory opinion, in the form of a declaratory judgment, as to what, in its view, Conseco Life could consider in implementing future cost of insurance rate increases related to its Valulife and Valuterm block of policies.  Conseco Life is appealing the court's January 19, 2011 decision and the plaintiff is appealing the court's decision to dismiss the California causes of action.  These appeals are pending. We believe this case is without merit and intend to defend it vigorously.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 15, 2011, a second complaint was filed by Dr. Yue in the United States District Court for the Central District on California, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Celedonia X. Yue, M. D. on behalf of the class of all others similarly situated, and on behalf of the General Public v. Conseco Life Insurance Company, Cause No. CV11-9506 AHM (SHx),</font><font style="font-family:inherit;font-size:10pt;"> involving the same Valulife universal life policy described in the preceding paragraph. Plaintiff, for herself and on behalf of proposed members of a national class and a California class is claiming breach of contract, injunctive and restitutionary relief pursuant to California Business & Professions Code Section 17200, breach of the covenant of good faith and fair dealing, declaratory relief, and temporary, preliminary, and permanent injunctive relief. The putative class consists of all owners and former owners of Valulife and Valuterm universal life insurance policies issued by either Massachusetts General or Philadelphia Life and that were later acquired and serviced by Conseco Life. Plaintiff alleges that members of the classes will be damaged by increases in the cost of insurance (a NGE) that took place on or about November 1, 2011. Plaintiff filed a motion for a preliminary injunction and a motion for certification of a California class. On April 2, 2012, the court granted the plaintiff's motions, which Conseco Life is appealing. Pending the outcome of that appeal, Conseco Life is preliminarily enjoined from imposing the 2011 increase in the cost of insurance on the members of the California class. Plaintiff also filed a motion on March 20, 2012 for certification of a nationwide class.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Conseco Life has agreed to a settlement with the plaintiff in the litigation described in the two preceding paragraphs, which would, upon court approval, resolve those cases as well as the Nicholas litigation described below. On January 25, 2013, the parties filed a stipulation of settlement and joint motion for preliminary approval of proposed nationwide class settlement and certification of settlement classes. The court set the hearing for preliminary approval of the settlement for February 25, 2013. The settlement includes a reduction in the cost of insurance increase implemented by Conseco Life in November 2011 and certain policy benefit enhancements. Final approval of the settlement is subject to a court fairness hearing after notice to the policyholders covered by the settlement, as well as other conditions.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 6, 2012, a complaint was filed in the United States District Court for the Northern District of Illinois, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Daniel B. Nicholas, on behalf of himself and all others similarly situated v. Conseco Life Insurance Company, Cause No. 12cv845.</font><font style="font-family:inherit;font-size:10pt;"> Plaintiff in this putative class action owns a Valulife universal life policy insuring Plaintiff's life originally issued by Massachusetts General Life Insurance Company (now Conseco Life Insurance Company) in 1991. Plaintiff is claiming breach of contract on behalf of the proposed national class and seeks declaratory, injunctive, and supplemental relief. The putative class consists of all persons who own or have owned one or more universal life policies issued by Conseco Life which provide that the cost of insurance rates will be determined based upon expectations as to future mortality experience and who have experienced an increase in the cost of insurance rates. On April 20, 2012, we announced that Conseco Life had reached a tentative settlement in the Nicholas case. Venue of this case was subsequently transferred to the United States District Court for the Central District of California. The settlement described in the preceding paragraph would, if approved, resolve the Nicholas case. </font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the tentative settlement in the Nicholas litigation, the Company recorded a pre-tax charge of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> in its Other CNO Business segment for the quarter ended March 31, 2012. The Company recorded an additional pre-tax charge of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$21 million</font><font style="font-family:inherit;font-size:10pt;"> in its Other CNO Business segment for the quarter ended September 30, 2012 relating to the settlement agreement described above in the Yue litigation. The liability the Company has established related to these cases includes its best estimates of the costs of implementing the settlement, if finalized and approved by the court. While the Company believes its estimates are adequate to cover these costs, the estimates are subject to significant judgment and it is possible that the estimates will prove insufficient to cover the actual costs. </font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Lifetrend Litigation</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 24, 2008, a purported class action was filed in the U.S. District Court for the Northern District of California, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cedric Brady, et. al. individually and on behalf of all other similarly situated v. Conseco, Inc. and Conseco Life Insurance Company Case No. 3:08-cv-05746.</font><font style="font-family:inherit;font-size:10pt;">  The plaintiffs allege that Conseco Life and Conseco, Inc. committed breach of contract and insurance bad faith and violated various consumer protection statutes in the administration of various interest sensitive whole life products sold primarily under the name "Lifetrend" by requiring the payment of additional cash amounts to maintain the policies in force and by making changes to certain NGEs in their policies.  On April 23, 2009, the plaintiffs filed an amended complaint adding the additional counts of breach of fiduciary duty, fraud, negligent misrepresentation, conversion and declaratory relief.  On May 29, 2009, Conseco, Inc. and Conseco Life filed a motion to dismiss the amended complaint. On July 29, 2009, the court granted in part and denied in part the motion to dismiss.  The court dismissed the allegations that Conseco Life violated various consumer protection statutes, the breach of fiduciary duty count, and dismissed Conseco, Inc. for lack of personal jurisdiction.  </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 2, 2009, a purported class action was filed in the U.S. District Court for the Middle District of Florida, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Bill W. McFarland, and all those similarly situated v. Conseco Life Insurance Company, Case No. 3:09-cv-598-J-32MCR.</font><font style="font-family:inherit;font-size:10pt;">  The plaintiff alleges that Conseco Life committed breach of contract and has been unjustly enriched in the administration, including changes to certain NGEs, of various interest sensitive whole life products sold primarily under the name "Lifetrend." The plaintiff seeks declaratory and injunctive relief, compensatory damages, punitive damages and attorney fees. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Conseco Life filed a motion with the Judicial Panel on Multidistrict Litigation ("MDL"), seeking the establishment of an MDL proceeding consolidating the Brady case and the McFarland case into a single action.  On February 3, 2010, the Judicial Panel on MDL ordered these cases be consolidated for pretrial proceedings in the Northern District of California Federal Court. On July 7, 2010, plaintiffs filed an amended motion for class certification of a nationwide class and a California state class.  On October 6, 2010, the court granted the motion for certification of a nationwide class and denied the motion for certification of a California state class.  Conseco Life filed a motion to decertify the nationwide class on July 1, 2011. On December 20, 2011, the court issued an order denying Conseco Life's motion to decertify the class as to current policyholders, but granted the motion to decertify as to former policyholders. On March 5, 2012, the plaintiffs filed a motion for a preliminary injunction requesting that the court enjoin Conseco Life from imposing increased cost of insurance charges until trial with regard to 157 members of the class, and on July 17, 2012, the court granted a preliminary injunction as to 100 members of the class and denied the plaintiff's motion for a preliminary injunction as to the other 57 members. Subsequently, the plaintiffs filed a motion for partial summary judgment on their breach of contract claim, Conseco Life filed a motion to decertify the nationwide class, and Conseco Life filed a motion for summary judgment. On January 29, 2013, the court granted in part and denied in part plaintiffs' motion for partial summary judgment and denied Conseco Life's motions. Trial in the MDL proceeding has been set for March 25, 2013.  We believe these cases are without merit and intend to defend them vigorously.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 25, 2012, a purported nationwide class action was filed in the United States District Court for the Central District of California, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">William Jeffrey Burnett and Joe H. Camp v. Conseco Life Insurance Company, CNO Financial Group, Inc., CDOC, Inc. and CNO Services, LLC, Case No. EDCV12-01715VAPSPX. </font><font style="font-family:inherit;font-size:10pt;">The plaintiffs bring this action under Rule 23(B)(3) on behalf of various Lifetrend policyholders who since October 2008 have surrendered their policies or had them lapse. Such policyholders are no longer members of the class covered by the MDL litigation described in the previous paragraph after the court in the MDL litigation granted Conseco Life's motion to decertify as to former policyholders. Additionally, plaintiffs seek certification of a subclass of various Lifetrend policyholders who accepted optional benefits and signed a release pursuant to the regulatory settlement agreement described below under the caption entitled "Regulatory Examinations and Fines." The plaintiffs allege breach of contract and seek declaratory relief, compensatory damages, attorney fees and costs. On November 30, 2012, Conseco Life and the other defendants filed a motion to dismiss the complaint. We believe this case is without merit and intend to defend it vigorously.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Litigation</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 8, 2008, a purported Florida state class action was filed in the U.S. District Court for the Southern District of Florida, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sydelle Ruderman individually and on behalf of all other similarly situated v. Washington National Insurance Company, Case No. 08-23401-CIV-Cohn/Selzer.</font><font style="font-family:inherit;font-size:10pt;"> The plaintiff alleges that the inflation escalation rider on her policy of long-term care insurance operates to increase the policy's lifetime maximum benefit, and that Washington National Insurance Company breached the contract by stopping her benefits when they reached the lifetime maximum.  The Company takes the position that the inflation escalator only affects the per day maximum benefit.  Additional parties have asked the court to allow them to intervene in the action, and on January 5, 2010, the court granted the motion to intervene and granted the plaintiff's motion for class certification.  The court certified a (B) (3) Florida state class alleging damages and a (B) (2) Florida state class alleging injunctive relief.  The parties reached a settlement of the (B) (3) class in 2010, which has been implemented. The amount recognized in 2010 related to the settlement was not significant to the Company's consolidated financial condition, cash flows or results of operations. The plaintiff filed a motion for summary judgment as to the (B) (2) class which was granted by the court on September 8, 2010.  The Company has appealed the court's decision and the appeal is pending.  On February 17, 2012, the Eleventh Circuit Court of Appeals referred the case to the Florida Supreme Court, which accepted jurisdiction of the case. On December 5, 2012, the Florida Supreme Court held oral argument and took the matter under advisement. We believe this case is without merit and intend to defend it vigorously.  </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 26, 2009, a purported class action complaint was filed in the United States District Court for the Northern District of Illinois, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Samuel Rowe and Estella Rowe, individually and on behalf of themselves and all others similarly situated v. Bankers Life & Casualty Company and Bankers Life Insurance Company of Illinois, Case No. 09CV491.</font><font style="font-family:inherit;font-size:10pt;">  The plaintiffs are alleging violation of California Business and Professions Code Sections 17200 et seq. and 17500 et seq., breach of common law fiduciary duty, breach of implied covenant of good faith and fair dealing and violation of California Welfare and Institutions Code Section 15600 on behalf of the proposed national class and seek injunctive relief, compensatory damages, punitive damages and attorney fees.  The plaintiffs allege that the defendants used an improper and misleading sales and marketing approach to seniors that fails to disclose all facts, misuses consumers' confidential financial information, uses misleading sales and marketing materials, promotes deferred annuities that are fundamentally inferior and less valuable than readily available alternative investment products and fails to adequately disclose other principal risks including maturity dates, surrender penalties and other restrictions which limit access to annuity proceeds to a date beyond the applicant's actuarial life expectancy. Plaintiffs have amended their complaint attempting to convert this from a California only class action to a national class action. In addition, the amended complaint adds causes of action under the Racketeer Influenced and Corrupt Organization Act ("RICO"); aiding and abetting breach of fiduciary duty and for unjust enrichment.  On September 13, 2010, the court dismissed the plaintiff's RICO claims.  On October 25, 2010, the plaintiffs filed a second amended complaint re-alleging their RICO claims.  On March 29, 2012, the court denied plaintiff's motion for certification of a nationwide class and denied plaintiff's motion for certification of a California class. The court allowed the plaintiff the opportunity to file a renewed motion for a California class, which the plaintiff did on May 21, 2012. On July 24, 2012, Bankers Life filed a motion for summary judgment. We believe this case is without merit and intend to defend it vigorously.  </font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 23, 2012, a purported class action was filed in the United States District Court for the District of Massachusetts (Boston), </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fay Glick, on behalf of herself and all others similarly situated, v. Bankers Life & Casualty Company, Case No. 1:12-cv-11579.</font><font style="font-family:inherit;font-size:10pt;"> The plaintiff is seeking injunctive and declaratory relief and damages arising from Bankers' alleged systematic business practices of delaying and/or denying the payment of claims for benefits provided for under its healthcare insurance policies and recovery of undisclosed interest that Bankers has charged on any policyholders who paid premiums on a monthly or "modal" basis (as opposed to paying premiums on an annual basis). On January 30, 2013, the court dismissed the modal premium related claims. Trial of the purported class claims has been set for December 2, 2013. We believe this case is without merit and intend to defend it vigorously.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Regulatory Examinations and Fines</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The states of Pennsylvania, Illinois, Texas, Florida and Indiana led a multistate examination of the long-term care claims administration and complaint handling practices of Senior Health and Bankers Life, as well as the sales and marketing practices of Bankers Life.  On May 7, 2008, we announced a settlement among the state insurance regulators and Senior Health and Bankers Life.  This examination covered the years 2005, 2006 and 2007.  More than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">40</font><font style="font-family:inherit;font-size:10pt;"> states are parties to the settlement, which included a Senior Health fine of up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;">, with up to an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> payable, on the part of either Senior Health and/or Bankers Life, in the event the process improvements and benchmarks are not met.  Pursuant to the settlement agreement, the lead states conducted a re-examination of Bankers Life to confirm compliance with the process improvements and benchmarks. On November 9, 2012, Bankers Life and the lead states executed a regulatory settlement agreement finalizing the re-examination, pursuant to which Bankers Life paid a fine of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.2 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2008, Conseco Life mailed notice to approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">12,000</font><font style="font-family:inherit;font-size:10pt;"> holders of its "Lifetrend" life insurance products to inform them of:  (i) changes to certain NGEs of their policies; and (ii) the fact that certain policyholders who were not paying premiums may have failed to receive a notice that their policy was underfunded and that additional premiums were required in order for the policyholders to maintain their guaranteed cash values.  In December 2008, Conseco Life mailed notice to approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16,000</font><font style="font-family:inherit;font-size:10pt;"> holders of its CIUL3+ universal life policies to inform them of an increase in certain NGEs with respect to their policies.  Prior to or around the time that the notices were sent, Conseco Life had informed the insurance regulators in a number of states, including among others Indiana, Iowa and Florida, of these matters and the planned communication with the impacted policyholders.  Several states initiated regulatory actions and inquiries after the notices were sent by Conseco Life, and Conseco Life agreed to take no further actions with respect to those policies during the pendency of a market conduct examination.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">After working with various state insurance regulators to review the terms of the Lifetrend and CIUL3+ policies, Conseco Life reached a settlement in principle with the regulators regarding issues involving these policies. During this regulatory review process, Conseco Life had been allowed to move forward with implementing the NGE changes in its CIUL3+ policies while the regulators continued their review.  Conseco Life had also resumed the administration of its Lifetrend policies with administrative changes in place but did not implement the NGE changes pending execution of the final settlement agreement with the regulators.  On June 30, 2010, we announced that Conseco Life had finalized a regulatory settlement agreement that requires the establishment of a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> fund for certain owners of its Lifetrend life insurance products and the payment of a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> assessment to participating jurisdictions.  Forty-seven jurisdictions, representing almost </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">98%</font><font style="font-family:inherit;font-size:10pt;"> percent of the Lifetrend policyholders, have signed the settlement agreement.  Conseco Life has notified consumers of the settlement and the increase in their NGEs.  As previously disclosed, we accrued for the financial impact of the settlement in our consolidated financial statements for year-end 2009.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">38</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia are currently participating in this examination.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Guaranty Fund Assessments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The balance sheet at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;">, included: (i) accruals of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$30.5 million</font><font style="font-family:inherit;font-size:10pt;">, representing our estimate of all known assessments that will be levied against the Company's insurance subsidiaries by various state guaranty associations based on premiums written through </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;">; and (ii) receivables of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$24.0 million</font><font style="font-family:inherit;font-size:10pt;"> that we estimate will be recovered through a reduction in future premium taxes as a result of such assessments. At </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2011</font><font style="font-family:inherit;font-size:10pt;">, such guaranty fund assessment accruals were </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$25.2 million</font><font style="font-family:inherit;font-size:10pt;"> and such receivables were </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$19.6 million</font><font style="font-family:inherit;font-size:10pt;">. These estimates are subject to change when the associations determine more precisely the losses that have occurred and how such losses will be allocated among the insurance companies. We recognized expense for such assessments of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2010</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Guarantees</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the terms of the employment agreements of two of the Company's former chief executive officers, certain wholly-owned subsidiaries of the Company are the guarantors of the former executives' nonqualified supplemental retirement benefits. The liability for such benefits was </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$24.8 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively, and is included in the caption "Other liabilities" in the consolidated balance sheet.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Leases and Certain Other Long-Term Commitments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company rents office space, equipment and computer software under noncancellable operating lease agreements. In addition, the Company has entered into certain sponsorship agreements which require future payments. Total expense pursuant to these lease and sponsorship agreements was </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$47.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$43.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$42.8 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2010</font><font style="font-family:inherit;font-size:10pt;">, respectively. Future required minimum payments as of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;">, were as follows (dollars in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75.5859375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="86%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2014</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>
CY2011	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	25200000	USD
CY2012	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	30500000	USD
CY2011Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1602800000	USD
CY2012Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1573200000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	613100000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	427300000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-291300000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1298600000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1338000000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-197100000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	774800000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	734000000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	634900000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	221000000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	335700000	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	240600000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	59100000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	65700000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-5000000	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	45400000	USD
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	64400000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	101200000	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	46400000	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	179500000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	233200000	USD
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	253900000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	350400000	USD
CY2011	us-gaap	Net Investment Income Insurance Entity NetInvestmentIncomeInsuranceEntity	1354100000	USD
CY2010	us-gaap	Net Investment Income Insurance Entity NetInvestmentIncomeInsuranceEntity	1366900000	USD
CY2012	us-gaap	Net Investment Income Insurance Entity NetInvestmentIncomeInsuranceEntity	1486400000	USD
CY2012Q4	us-gaap	Notes Payable NotesPayable	1004200000	USD
CY2011Q4	us-gaap	Notes Payable NotesPayable	857900000	USD
CY2012Q4	us-gaap	Other Assets OtherAssets	334000000	USD
CY2011Q4	us-gaap	Other Assets OtherAssets	292200000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	636300000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	823400000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	819200000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	526700000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	528900000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	415800000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	68700000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	101000000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	97200000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	-114000000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	5000000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	38000000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-294500000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-292500000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-220500000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1336200000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1357700000	USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1052200000	USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	462200000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	407800000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	528700000	USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	256300000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	294400000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	216100000	USD
CY2012	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	819300000	USD
CY2010	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	690300000	USD
CY2011	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	704500000	USD
CY2011Q4	us-gaap	Other Investments OtherInvestments	202800000	USD
CY2012Q4	us-gaap	Other Investments OtherInvestments	248100000	USD
CY2012Q4	us-gaap	Other Liabilities OtherLiabilities	570600000	USD
CY2011Q4	us-gaap	Other Liabilities OtherLiabilities	556300000	USD
CY2010	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	36000000	USD
CY2011	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	12600000	USD
CY2012	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	14000000	USD
CY2012Q4	us-gaap	Other Tax Carryforward Gross Amount OtherTaxCarryforwardGrossAmount	846300000	USD
CY2010	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	94800000	USD
CY2011	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	19200000	USD
CY2012	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	1000000	USD
CY2012	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterest	0	USD
CY2010	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterest	4700000	USD
CY2011	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterest	-5300000	USD
CY2012	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2010	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	3000000	USD
CY2011	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-5300000	USD
CY2010	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	-149800000	USD
CY2012	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	-37800000	USD
CY2011	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	-34600000	USD
CY2011	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	34600000	USD
CY2012	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	37800000	USD
CY2010	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	149800000	USD
CY2012	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	786700000	USD
CY2011	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	684300000	USD
CY2010	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	637800000	USD
CY2011	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	32500000	USD
CY2010	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	14700000	USD
CY2012	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	31600000	USD
CY2010	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	180200000	USD
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	69800000	USD
CY2011	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2012	us-gaap	Payments Of Dividends PaymentsOfDividends	13900000	USD
CY2010	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2012	us-gaap	Percentage Of Amount Amortized Of Ending Present Value Of Future Insurance Profits Year Five PercentageOfAmountAmortizedOfEndingPresentValueOfFutureInsuranceProfitsYearFive	0.06
CY2012	us-gaap	Percentage Of Amount Amortized Of Ending Present Value Of Future Insurance Profits Year Four PercentageOfAmountAmortizedOfEndingPresentValueOfFutureInsuranceProfitsYearFour	0.07
CY2012	us-gaap	Percentage Of Amount Amortized Of Ending Present Value Of Future Insurance Profits Year One PercentageOfAmountAmortizedOfEndingPresentValueOfFutureInsuranceProfitsYearOne	0.09
CY2012	us-gaap	Percentage Of Amount Amortized Of Ending Present Value Of Future Insurance Profits Year Three PercentageOfAmountAmortizedOfEndingPresentValueOfFutureInsuranceProfitsYearThree	0.07
CY2012	us-gaap	Percentage Of Amount Amortized Of Ending Present Value Of Future Insurance Profits Year Two PercentageOfAmountAmortizedOfEndingPresentValueOfFutureInsuranceProfitsYearTwo	0.08
CY2012Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	272000000	USD
CY2011Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	279700000	USD
CY2011	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2699000000	USD
CY2010	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2723700000	USD
CY2012	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2763900000	USD
CY2010	us-gaap	Premiums Earned Net PremiumsEarnedNet	2670000000	USD
CY2011	us-gaap	Premiums Earned Net PremiumsEarnedNet	2690500000	USD
CY2012	us-gaap	Premiums Earned Net PremiumsEarnedNet	2755400000	USD
CY2010	us-gaap	Premiums Written Net PremiumsWrittenNet	4086700000	USD
CY2012	us-gaap	Premiums Written Net PremiumsWrittenNet	3716400000	USD
CY2011	us-gaap	Premiums Written Net PremiumsWrittenNet	4059200000	USD
CY2012Q4	us-gaap	Present Value Of Future Insurance Profits PresentValueOfFutureInsuranceProfits	626000000	USD
CY2009Q4	us-gaap	Present Value Of Future Insurance Profits PresentValueOfFutureInsuranceProfits	1175900000	USD
CY2011Q4	us-gaap	Present Value Of Future Insurance Profits PresentValueOfFutureInsuranceProfits	697700000	USD
CY2010Q4	us-gaap	Present Value Of Future Insurance Profits PresentValueOfFutureInsuranceProfits	1008600000	USD
CY2011	us-gaap	Present Value Of Future Insurance Profits Amortization Expense PresentValueOfFutureInsuranceProfitsAmortizationExpense	113700000	USD
CY2012	us-gaap	Present Value Of Future Insurance Profits Amortization Expense PresentValueOfFutureInsuranceProfitsAmortizationExpense	93500000	USD
CY2010	us-gaap	Present Value Of Future Insurance Profits Amortization Expense PresentValueOfFutureInsuranceProfitsAmortizationExpense	139000000	USD
CY2012	us-gaap	Present Value Of Future Insurance Profits Unrealized Investment Gains PresentValueOfFutureInsuranceProfitsUnrealizedInvestmentGains	21800000	USD
CY2010	us-gaap	Present Value Of Future Insurance Profits Unrealized Investment Gains PresentValueOfFutureInsuranceProfitsUnrealizedInvestmentGains	-28300000	USD
CY2011	us-gaap	Present Value Of Future Insurance Profits Unrealized Investment Gains PresentValueOfFutureInsuranceProfitsUnrealizedInvestmentGains	-197200000	USD
CY2012	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1296700000	USD
CY2010	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1730100000	USD
CY2011	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1693500000	USD
CY2012	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	375000000	USD
CY2010	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	787000000	USD
CY2011	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	717000000	USD
CY2012	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	19800000	USD
CY2011	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	18200000	USD
CY2010	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	16800000	USD
CY2011	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2382800000	USD
CY2010	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2359300000	USD
CY2012	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2419700000	USD
CY2010	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1304900000	USD
CY2011	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1418600000	USD
CY2012	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1385800000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2200000	USD
CY2010	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3100000	USD
CY2010	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	756100000	USD
CY2011	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2012	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	944500000	USD
CY2012Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	944500000	USD
CY2011	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	24800000	USD
CY2010	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2012	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	-24800000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3100000	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2200000	USD
CY2012	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	210200000	USD
CY2010	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	471600000	USD
CY2011	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	204900000	USD
CY2011	us-gaap	Reinsurance Premiums For Insurance Companies By Product Segment Amount Assumed From Other Companies ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountAssumedFromOtherCompanies	87700000	USD
CY2012	us-gaap	Reinsurance Premiums For Insurance Companies By Product Segment Amount Assumed From Other Companies ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountAssumedFromOtherCompanies	70400000	USD
CY2010	us-gaap	Reinsurance Premiums For Insurance Companies By Product Segment Amount Assumed From Other Companies ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountAssumedFromOtherCompanies	99400000	USD
CY2012	us-gaap	Reinsurance Premiums For Insurance Companies By Product Segment Amount Ceded To Other Companies ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountCededToOtherCompanies	237100000	USD
CY2011	us-gaap	Reinsurance Premiums For Insurance Companies By Product Segment Amount Ceded To Other Companies ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountCededToOtherCompanies	243200000	USD
CY2010	us-gaap	Reinsurance Premiums For Insurance Companies By Product Segment Amount Ceded To Other Companies ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountCededToOtherCompanies	264700000	USD
CY2012Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	2927700000	USD
CY2011Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	3091100000	USD
CY2012	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1544900000	USD
CY2011	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1664300000	USD
CY2010	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1704400000	USD
CY2010	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	37000000	USD
CY2012	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	375000000	USD
CY2011	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	267000000	USD
CY2010	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	793600000	USD
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	810600000	USD
CY2011	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	144800000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-325000000	USD

CY2011Q4

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

19600000

USD

CY2012Q4

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

25700000

USD

CY2012Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

286200000

USD

CY2011Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

288700000

USD

CY2011Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

781600000

USD

CY2012Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

1197400000

USD

CY2011Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

4361900000

USD

CY2012Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

4174700000

USD

CY2010

us-gaap

Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature

AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature

4000000

USD

CY2011

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

297400000

USD

CY2010

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

325000000

USD

CY2012

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

289000000

USD

CY2012Q4

us-gaap

Assets

34131400000

USD

CY2011Q4

us-gaap

Assets

32921900000

USD

CY2012Q4

us-gaap

Assets Held By Insurance Regulators

AssetsHeldByInsuranceRegulators

67800000

USD

CY2011Q4

us-gaap

Assets Held By Insurance Regulators

AssetsHeldByInsuranceRegulators

74500000

USD

CY2010

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

92600000

USD

CY2012

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

69400000

USD

CY2011

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

80400000

USD

CY2011Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

21779100000

USD

CY2012Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

21626800000

USD

CY2012Q4

us-gaap

Available For Sale Equity Securities Amortized Cost Basis

AvailableForSaleEquitySecuritiesAmortizedCostBasis

167100000

USD

CY2011Q4

us-gaap

Available For Sale Equity Securities Amortized Cost Basis

AvailableForSaleEquitySecuritiesAmortizedCostBasis

177000000

USD

CY2012Q4

us-gaap

Available For Sale Securities Continuous Unrealized Loss Position Fair Value

AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue

908600000

USD

CY2011Q4

us-gaap

Available For Sale Securities Continuous Unrealized Loss Position Fair Value

AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue

3768500000

USD

CY2012Q4

us-gaap

Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value

AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue

479400000

USD

CY2011Q4

us-gaap

Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value

AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue

2932600000

USD

CY2012Q4

us-gaap

Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value

AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue

429200000

USD

CY2011Q4

us-gaap

Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value

AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue

835900000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost

4375000000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue

4932700000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

1605000000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

1754500000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities After Ten Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost

10390700000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities After Ten Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue

12225100000

USD

CY2011Q4

us-gaap

Available For Sale Securities Debt Maturities Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost

21779100000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost

21626800000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

167600000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Fair Value

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

170200000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost

5088500000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue

5531600000

USD

CY2011Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

23516000000

USD

CY2012Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

24614100000

USD

CY2011Q4

us-gaap

Available For Sale Securities Equity Securities

AvailableForSaleSecuritiesEquitySecurities

175100000

USD

CY2012Q4

us-gaap

Available For Sale Securities Equity Securities

AvailableForSaleSecuritiesEquitySecurities

171400000

USD

CY2011Q4

us-gaap

Available For Sale Securities Fair Value Disclosure

AvailableForSaleSecuritiesFairValueDisclosure

23516000000

USD

CY2012Q4

us-gaap

Available For Sale Securities Fair Value Disclosure

AvailableForSaleSecuritiesFairValueDisclosure

24614100000

USD

CY2010

us-gaap

Available For Sale Securities Gross Realized Gains

AvailableForSaleSecuritiesGrossRealizedGains

347100000

USD

CY2011

us-gaap

Available For Sale Securities Gross Realized Gains

AvailableForSaleSecuritiesGrossRealizedGains

183100000

USD

CY2012

us-gaap

Available For Sale Securities Gross Realized Gains

AvailableForSaleSecuritiesGrossRealizedGains

115400000

USD

CY2011Q4

us-gaap

Available For Sale Securities Gross Unrealized Losses1

AvailableForSaleSecuritiesGrossUnrealizedLosses1

222900000

USD

CY2012Q4

us-gaap

Available For Sale Securities Gross Unrealized Losses1

AvailableForSaleSecuritiesGrossUnrealizedLosses1

32900000

USD

CY2012Q4

us-gaap

Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2

AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2

18700000

USD

CY2011Q4

us-gaap

Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2

AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2

118900000

USD

CY2012Q4

us-gaap

Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2

AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2

32900000

USD

CY2011Q4

us-gaap

Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2

AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2

222900000

USD

CY2012Q4

us-gaap

Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2

AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2

14200000

USD

CY2011Q4

us-gaap

Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2

AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2

104000000

USD

CY2011Q4

us-gaap

Availableforsale Securities Gross Unrealized Gain

AvailableforsaleSecuritiesGrossUnrealizedGain

1959800000

USD

CY2012Q4

us-gaap

Availableforsale Securities Gross Unrealized Gain

AvailableforsaleSecuritiesGrossUnrealizedGain

3020200000

USD

CY2010

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3859000000

USD

CY2011

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3818400000

USD

CY2012

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

4187000000

USD

CY2011Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

436000000

USD

CY2012Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

582500000

USD

CY2010Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

571900000

USD

CY2009Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

523400000

USD

CY2010

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

48500000

USD

CY2011

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

-135900000

USD

CY2012

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

146500000

USD

CY2010

us-gaap

Ceded Premiums Written

CededPremiumsWritten

258600000

USD

CY2012

us-gaap

Ceded Premiums Written

CededPremiumsWritten

220000000

USD

CY2011

us-gaap

Ceded Premiums Written

CededPremiumsWritten

238100000

USD

CY2012Q4

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights

6.50

CY2012Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2011Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2012Q4

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.02

CY2011Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2012Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2011Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

8000000000

shares

CY2012Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

8000000000

shares

CY2012Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

221502371

shares

CY2011Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

241304503

shares

CY2011Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

241304503

shares

CY2012Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

221502371

shares

CY2012Q4

us-gaap

Common Stock Value

CommonStockValue

2200000

USD

CY2011Q4

us-gaap

Common Stock Value

CommonStockValue

2400000

USD

CY2012

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

636800000

USD

CY2010

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

767300000

USD

CY2011

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

864600000

USD

CY2012

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

12500000

USD

CY2010

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

9700000

USD

CY2011

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

11900000

USD

CY2012Q4

us-gaap

Debt Instrument Convertible Conversion Price1

DebtInstrumentConvertibleConversionPrice1

5.49

CY2010

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

69600000

USD

CY2011

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

101600000

USD

CY2012

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

117400000

USD

CY2011

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-143000000

USD

CY2012

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-171500000

USD

CY2010

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-95000000

USD

CY2012

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

195500000

USD

CY2011

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

183700000

USD

CY2010

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

186000000

USD

CY2012Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

629700000

USD

CY2011Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

797100000

USD

CY2012

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

191700000

USD

CY2010

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

231800000

USD

CY2011

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

216700000

USD

CY2010Q4

us-gaap

Deferred Policy Acquisition Costs Net

DeferredPolicyAcquisitionCostsNet

999600000

USD

CY2012Q4

us-gaap

Deferred Policy Acquisition Costs Net

DeferredPolicyAcquisitionCostsNet

629700000

USD

CY2009Q4

us-gaap

Deferred Policy Acquisition Costs Net

DeferredPolicyAcquisitionCostsNet

1063000000

USD

CY2011Q4

us-gaap

Deferred Policy Acquisition Costs Net

DeferredPolicyAcquisitionCostsNet

797100000

USD

CY2012

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

4400000

USD

CY2011

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

11500000

USD

CY2010

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

20000000

USD

CY2011

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

28700000

USD

CY2010

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

31200000

USD

CY2012

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

27100000

USD

CY2012Q4

us-gaap

Deferred Sales Inducements Net

DeferredSalesInducementsNet

126500000

USD

CY2011Q4

us-gaap

Deferred Sales Inducements Net

DeferredSalesInducementsNet

149200000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Capital Loss Carryforwards

DeferredTaxAssetsCapitalLossCarryforwards

296200000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Capital Loss Carryforwards

DeferredTaxAssetsCapitalLossCarryforwards

342300000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

2646100000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

2514100000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

716900000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

865400000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

885000000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

742600000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Domestic

DeferredTaxAssetsOperatingLossCarryforwardsDomestic

1330200000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Domestic

DeferredTaxAssetsOperatingLossCarryforwardsDomestic

1445200000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

16800000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

16200000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

64800000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

86000000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Tax Credit Carryforwards General Business

DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness

39200000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Tax Credit Carryforwards General Business

DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness

32600000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

746300000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

744400000

USD

CY2012Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

766900000

USD

CY2011Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

938400000

USD

CY2011Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

822700000

USD

CY2012Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

1004600000

USD

CY2011Q4

us-gaap

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

363700000

USD

CY2012Q4

us-gaap

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

325200000

USD

CY2011Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

24200000

USD

CY2012Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

24100000

USD

CY2011Q4

us-gaap

Deferred Tax Liabilities Other Comprehensive Income

DeferredTaxLiabilitiesOtherComprehensiveIncome

-434800000

USD

CY2012Q4

us-gaap

Deferred Tax Liabilities Other Comprehensive Income

DeferredTaxLiabilitiesOtherComprehensiveIncome

-655300000

USD

CY2011

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

4500000

USD

CY2010

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

4100000

USD

CY2012

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

4500000

USD

CY2012

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

315000000

USD

CY2011

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

323600000

USD

CY2010

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

346500000

USD

CY2012

us-gaap

Derivatives Methods Of Accounting Nonhedging Derivatives

DerivativesMethodsOfAccountingNonhedgingDerivatives

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting for Derivatives</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.  We reflect changes in the estimated fair value of these options in net investment income (classified as investment income from policyholder and reinsurer accounts and other special-purpose portfolios).  Net investment gains (losses) related to fixed index products were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$(21.2) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$28.2 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2010</font><font style="font-family:inherit;font-size:10pt;">, respectively. These amounts were substantially offset by a corresponding change to insurance policy benefits.  The estimated fair value of these options was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$54.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$37.9 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively.  We classify these instruments as other invested assets.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for the options attributed to the policyholder for the estimated life of the annuity contract as embedded derivatives.  The Company purchases options to hedge liabilities for the next policy year on each policy anniversary date and must estimate the fair value of the forward embedded options related to the policies.  These accounting requirements often create volatility in the earnings from these products.  We record the changes in the fair values of the embedded derivatives in earnings as a component of insurance policy benefits.  The fair value of these derivatives, which are classified as "liabilities for interest-sensitive products", was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$734.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$666.3 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively. Prior to June 30, 2011, we maintained a specific block of investments in our trading securities account (which we carried at estimated fair value with changes in such value recognized as investment income from policyholder and reinsurer accounts and other special-purpose portfolios) to offset the income statement volatility caused by the effect of interest rate fluctuations on the value of embedded derivatives related to our fixed index annuity products.  During the second quarter of 2011, we sold this trading portfolio. Because we no longer seek to offset changes from the effect of interest rates on derivative embedded in our fixed index annuity products, we recognized </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20.4 million</font><font style="font-family:inherit;font-size:10pt;"> of decreased earnings in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively, since the volatility caused by the accounting requirements to record embedded options at fair value was no longer being offset.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the counterparties for the call options we hold fail to meet their obligations, we may have to recognize a loss.  We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy.  At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;">, substantially all of our counterparties were rated "BBB+" or higher by Standard & Poor's Corporation ("S&P").</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of our reinsurance payable balances contain embedded derivatives.  Such derivatives had an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively.  We record the change in the fair value of these derivatives as a component of investment income (classified as investment income from policyholder and reinsurer accounts and other special-purpose portfolios).  We maintain the investments related to these agreements in our trading securities account, which we carry at estimated fair value with changes in such value recognized as investment income (also classified as investment income from policyholder and reinsurer accounts and other special-purpose portfolios).  The change in value of these trading securities offsets the change in value of the embedded derivatives.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We purchase certain fixed maturity securities that contain embedded derivatives that are required to be bifurcated from the instrument and held at fair value on the consolidated balance sheet. For certain of these securities, we have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income for operational ease.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

CY2011

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4214700000

USD

CY2012

us-gaap

Direct Premiums Written

DirectPremiumsWritten

3883100000

USD

CY2010

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4252000000

USD

CY2012

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

13900000

USD

CY2011

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.35

CY2010

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.96

CY2012

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.95

CY2011Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.73

CY2011Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.18

CY2011Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.18

CY2012Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-0.02

CY2011Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.27

CY2012Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.28

CY2012Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.45

CY2012Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.25

CY2011

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.15

CY2010

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.84

CY2012

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.83

CY2011Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.16

CY2012Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.24

CY2011Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.16

CY2012Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.41

CY2011Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.61

CY2012Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-0.02

CY2012Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.21

CY2011Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.23

CY2012

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.419

CY2010

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.070

CY2011

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.096

CY2012

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.350

CY2010

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.350

CY2011

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.350

CY2011

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.467

CY2010

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.422

CY2012

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-1.101

CY2010

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Other

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther

-0.006

CY2011

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Other

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther

0.007

CY2012

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Other

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther

0.323

CY2010

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.001

CY2011

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0.005

CY2012

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.005

CY2010

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.009

CY2012

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.014

CY2011

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.009

CY2010

us-gaap

Embedded Derivative Gain Loss On Embedded Derivative Net

EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet

0

USD

CY2011

us-gaap

Embedded Derivative Gain Loss On Embedded Derivative Net

EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet

-34400000

USD

CY2012

us-gaap

Embedded Derivative Gain Loss On Embedded Derivative Net

EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet

-4400000

USD

CY2011

us-gaap

Extinguishment Of Debt Gain Loss Income Tax

ExtinguishmentOfDebtGainLossIncomeTax

0

USD

CY2010

us-gaap

Extinguishment Of Debt Gain Loss Income Tax

ExtinguishmentOfDebtGainLossIncomeTax

0

USD

CY2012

us-gaap

Extinguishment Of Debt Gain Loss Income Tax

ExtinguishmentOfDebtGainLossIncomeTax

-23700000

USD

CY2012

us-gaap

Fees And Commissions

FeesAndCommissions

19800000

USD

CY2010

us-gaap

Fees And Commissions

FeesAndCommissions

16800000

USD

CY2011

us-gaap

Fees And Commissions

FeesAndCommissions

18200000

USD

CY2012

us-gaap

Gain Loss On Investments

GainLossOnInvestments

81100000

USD

CY2011

us-gaap

Gain Loss On Investments

GainLossOnInvestments

61800000

USD

CY2010

us-gaap

Gain Loss On Investments

GainLossOnInvestments

30200000

USD

CY2010

us-gaap

Gain Loss On Investments Excluding Other Than Temporary Impairments

GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments

180000000

USD

CY2012

us-gaap

Gain Loss On Investments Excluding Other Than Temporary Impairments

GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments

118900000

USD

CY2011

us-gaap

Gain Loss On Investments Excluding Other Than Temporary Impairments

GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments

96400000

USD

CY2010

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-6800000

USD

CY2012

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-200200000

USD

CY2011

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-3400000

USD

CY2010

us-gaap

Impairment Of Investments

ImpairmentOfInvestments

146800000

USD

CY2011

us-gaap

Impairment Of Investments

ImpairmentOfInvestments

39900000

USD

CY2012

us-gaap

Impairment Of Investments

ImpairmentOfInvestments

37800000

USD

CY2010

us-gaap

Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments